UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

Circulation (New York, N.Y.), 2004-09, Vol.110 (10), p.1245-1250

2004

Volltextzugriff (PDF)

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics

Frontiers in medicine, 2021-12, Vol.8, p.802989-802989

2021

Volltextzugriff (PDF)

Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease

Journal of allergy and clinical immunology, 2007-08, Vol.120 (2), p.396-402

2007

Volltextzugriff (PDF)

Economic burden of impairment in children with severe or difficult-to-treat asthma

Annals of allergy, asthma, & immunology, 2011-08, Vol.107 (2), p.110-119.e1

2011

Volltextzugriff (PDF)

Durability of Protection Post–Primary COVID-19 Vaccination in the United States

Vaccines (Basel), 2022-09, Vol.10 (9), p.1458

2022

Volltextzugriff (PDF)

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome

The American journal of cardiology, 2003-06, Vol.91 (12), p.1421-1426

2003

Volltextzugriff (PDF)

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

JAMA network open, 2022-03, Vol.5 (3), p.e222959-e222959

2022

Volltextzugriff (PDF)

515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S359-S360

2021

Volltextzugriff (PDF)

2659. Substantially Elevated Influenza Risk in Vaccinated Immunocompromised Adults and High-Risk Patients Relative to All Vaccinated

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer

Breast cancer research and treatment, 2016-05, Vol.157 (1), p.145-156

2016

Volltextzugriff (PDF)

Individual attributions of living longer with HER2+ metastatic breast cancer: Findings from a community web-based survey

Journal of clinical oncology, 2014-10, Vol.32 (30_suppl), p.197-197

2014

Volltextzugriff (PDF)

Projecting the cost-effectiveness of pertuzumab with trastuzumab and docetaxel in the neoadjuvant treatment of HER2-positive, locally advanced, inflammatory or early breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.642-642

2014

Volltextzugriff (PDF)

Abstract P5-21-03: Delay in trastuzumab initiation leads to decreased overall survival in patients with HER2+ early stage breast cancer

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-21-03

2015

Volltextzugriff (PDF)

Relapse impact on overall survival in trastuzumab-treated women with HER2+ early-stage breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e11601-e11601

2014

Volltextzugriff (PDF)

Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001

Canadian journal of cardiology, 2004-06, Vol.20 (8), p.767-772

2004

Volltextzugriff (PDF)

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens

SpringerPlus, 2014-05, Vol.3 (1), p.259-259, Article 259

2014

Volltextzugriff (PDF)

Poor disease control among insured users of high-dose combination therapy for asthma

Allergy and asthma proceedings, 2010-01, Vol.31 (1), p.60-67

2010

Volltextzugriff (PDF)

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice

SpringerPlus, 2016-03, Vol.5 (1), p.395-395, Article 395

2016

Volltextzugriff (PDF)

Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population

Allergy and asthma proceedings, 2009-03, Vol.30 (2), p.148-157

2009

Volltextzugriff (PDF)

Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis

Rheumatology and therapy., 2014-12, Vol.1 (1), p.21-30

2014

Volltextzugriff (PDF)

Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan

Journal of managed care pharmacy, 2006-07, Vol.12 (6), p.472-478

2006

Volltextzugriff (PDF)

ASSESSING THE IMPACT OF ASTHMA CONTROL ON QUALITY OF LIFE IN PATIENTS WITH SEVERE OR DIFFICULT-TO-TREAT ASTHMA

Chest, 2006-10, Vol.130 (4), p.95S-95S

2006

Volltextzugriff (PDF)

Preventing coronary events by control of lipids and blood pressure in persons with the metabolic syndrome

Journal of the American College of Cardiology, 2003-03, Vol.41 (6), p.268-268

2003

Volltextzugriff (PDF)

Physician adherence to national hypertension guidelines in an elderly Medicaid population

Kamath, Tripthi Vasant

2001

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(23)
Dissertationen
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics

Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease

Economic burden of impairment in children with severe or difficult-to-treat asthma

Durability of Protection Post–Primary COVID-19 Vaccination in the United States

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States

2659. Substantially Elevated Influenza Risk in Vaccinated Immunocompromised Adults and High-Risk Patients Relative to All Vaccinated

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer

Individual attributions of living longer with HER2+ metastatic breast cancer: Findings from a community web-based survey

Projecting the cost-effectiveness of pertuzumab with trastuzumab and docetaxel in the neoadjuvant treatment of HER2-positive, locally advanced, inflammatory or early breast cancer

Abstract P5-21-03: Delay in trastuzumab initiation leads to decreased overall survival in patients with HER2+ early stage breast cancer

Relapse impact on overall survival in trastuzumab-treated women with HER2+ early-stage breast cancer

Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens

Poor disease control among insured users of high-dose combination therapy for asthma

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice

Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population

Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis

Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan

ASSESSING THE IMPACT OF ASTHMA CONTROL ON QUALITY OF LIFE IN PATIENTS WITH SEVERE OR DIFFICULT-TO-TREAT ASTHMA

Preventing coronary events by control of lipids and blood pressure in persons with the metabolic syndrome

Physician adherence to national hypertension guidelines in an elderly Medicaid population

Suchergebnisse filtern